Chelsea M. Byrd, Ph.D.
Affiliations: | 2005 | Oregon State University, Corvallis, OR |
Area:
Molecular Biology, Microbiology BiologyGoogle:
"Chelsea Byrd"Parents
Sign in to add mentorDennis E. Hruby | grad student | 2005 | Oregon State | |
(Vaccinia virus I7L core protein proteinase.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Scaturro P, Trist IM, Paul D, et al. (2014) Characterization of the mode of action of a potent dengue virus capsid inhibitor. Journal of Virology. 88: 11540-55 |
Byrd CM, Grosenbach DW, Hruby DE. (2013) Antiviral options for biodefense. Current Opinion in Virology. 3: 537-41 |
Byrd CM, Grosenbach DW, Berhanu A, et al. (2013) Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicase. Antimicrobial Agents and Chemotherapy. 57: 1902-12 |
Santos-Fernandes É, Beltrame CO, Byrd CM, et al. (2013) Increased susceptibility of Cantagalo virus to the antiviral effect of ST-246®. Antiviral Research. 97: 301-11 |
Byrd CM, Dai D, Grosenbach DW, et al. (2013) A novel inhibitor of dengue virus replication that targets the capsid protein. Antimicrobial Agents and Chemotherapy. 57: 15-25 |
Byrd CM, Bolken TC, Hruby DE. (2013) Vaccinia Virus Cysteine Proteinase Handbook of Proteolytic Enzymes. 2: 2390-2392 |
Byrd CM, Bolken TC, Hruby DE. (2013) Vaccinia Virus Metalloproteinase Handbook of Proteolytic Enzymes. 1: 1462-1464 |
Byrd CM, Hruby DE. (2012) Screening for vaccinia virus egress inhibitors: separation of IMV, IEV, and EEV. Methods in Molecular Biology (Clifton, N.J.). 890: 113-21 |
Byrd C, Harver C, Cardwell K, et al. (2010) Small Molecule Inhibitors of Dengue Virus Replication are Active In Vivo Antiviral Research. 86: A30-A31 |
Byrd CM, Hruby DE. (2010) Need for dengue virus drug discovery Handbook of Disease Outbreaks: Prevention, Detection and Control. 343-349 |